FfyeUgDWYAABqU4

Jerry kruger on October 24, 2022

146 views

In Album: Jerry kruger's Timeline Photos

Dimension: 679 x 442

File Size: 105.6 Kb

View More View Less

7 people like this.

Roberto Lopez

ATTENTION: Dr. David Martin won a lawsuit against the order of "masks" on planes But he won't stop there... View MoreATTENTION: Dr. David Martin won a lawsuit against the order of "masks" on planes But he won't stop there "It's about the criminals of the poison" Here is his resume: Resume of Dr. David Martin His titles: 1. Dr. David E. Martin is the founder and president of M-CAM Inc, an international leader in financing innovation, trade and financing of intangible assets. He is the creator of the first innovation-based quantitative public equity index and is the managing partner of Purple Bridge Funds. He is the creator of the world's first quantitative public equity index: the CNBC IQ100 powered by M-CAM. Actively involved in global ethical economic development, Dr. Martin's work includes financial and investment engineering, public speaking, writing, and providing financial advisory services to most countries around the world. Dr. Martin is the architect and founder of the Global Innovation Commons and is the author of the international legal framework for the Heritable Knowledge Trust and Heritable Innovation Trust programs. He has pioneered global programs to bring corporate and stock market transparency to multinational extractive industries and has been instrumental in repatriating value to countries that have been subject to corporate and financial abuse. His work on ethical engagement and stewardship of community-based value interests and the commons is at the forefront of global financial innovation. Dr. Martin is a Batten Scholar at the University of Virginia Darden Graduate School of Business Administration. He has been Chair of Economic Innovation at the UN-affiliated Intergovernmental Renewable Energy Organization and has been an advisor to numerous central banks, world economic forums, the World Bank and the International Finance Corporation, as well as national governments. 2. Dr. Judy Mikovits received her bachelor's degree in chemistry with a minor in biology from the University of Virginia in 1980 and her Ph.D. in biochemistry and molecular biology from George Washington University in 1992. Upon graduating from the University of Virginia, she joined the National Cancer Institute in Frederick Maryland, where she developed purification methods for interferon alpha. It was this interferon that was used in the first immunotherapy treatment for hairy cell leukemia in 1986. In 1986-7, before enrolling in graduate school, he went to Upjohn Pharmaceuticals in Kalamazoo Michigan to develop production methods that would ensure that biological materials made from human blood products were not contaminated by HIV-1. Source: TRIKOOBA.COM The 'COVID vaccine' is not a vaccine, say doctors David Martin and Judy Mikovits 30 January 2021 "it's an operating system" It is NOT a vaccine. The mRNA COVID vaccine being rolled out in many countries around the world is NOT a vaccine. I repeat: it is not a vaccine. They are many things, but a vaccine is not one of them. We need to wake up to the fact that the farce of the COVID pandemic has rapidly accelerated the technocratic and transhumanist aspects of New World Order (NWO) to the point where people are blindly lining up to be injected with a "treatment" that is also a chemical device, an operating system, a synthetic pathogen, and a chemical pathogen production device.

View Less

Like October 24, 2022

Roberto Lopez

Dr.David Martin Resume Sus titulos: ... View MoreDr.David Martin Resume Sus titulos: 1. El Dr. David E. Martin es el fundador y presidente de M-CAM Inc, líder internacional en financiación de la innovación, comercio y financiación de activos intangibles. Es el creador del primer índice cuantitativo de acciones públicas basado en la innovación y es el socio gerente de los Purple Bridge Funds. Es el creador del primer índice cuantitativo de acciones públicas del mundo: el CNBC IQ100 powered by M-CAM. Comprometido activamente con el desarrollo económico ético global, el trabajo del Dr. Martin incluye la ingeniería financiera y la inversión, la oratoria, la escritura y la prestación de servicios de asesoramiento financiero a la mayoría de los países del mundo. El Dr. Martin es el arquitecto y fundador del Global Innovation Commons y es el autor del marco jurídico internacional de los programas Heritable Knowledge Trust y Heritable Innovation Trust. Ha sido pionero en programas mundiales para aportar transparencia empresarial y bursátil a las industrias extractivas multinacionales y ha sido fundamental en la repatriación de valor a países que han sido objeto de abusos empresariales y financieros. Su trabajo sobre el compromiso ético y la administración de los intereses de valor basados en la comunidad y los bienes comunes está a la vanguardia de la innovación financiera mundial. El Dr. Martin es becario Batten en la Darden Graduate School of Business Administration de la Universidad de Virginia. Ha sido Presidente de Innovación Económica de la Organización Intergubernamental de Energías Renovables, afiliada a la ONU, y ha sido asesor de numerosos bancos centrales, foros económicos mundiales, el Banco Mundial y la Corporación Financiera Internacional, así como de gobiernos nacionales. 2. La Dra. Judy Mikovits se licenció en química con especialización en biología por la Universidad de Virginia en 1980 y se doctoró en bioquímica y biología molecular por la Universidad George Washington en 1992. Al graduarse en la Universidad de Virginia, se incorporó directamente al Instituto Nacional del Cáncer en Frederick Maryland, donde desarrolló métodos de purificación del interferón alfa. Fue este interferón el que se utilizó en el primer tratamiento de inmunoterapia para la leucemia de células pilosas en 1986. En 1986-7, antes de matricularse en la escuela de posgrado, fue a Upjohn Pharmaceuticals en Kalamazoo Michigan para desarrollar métodos de producción que aseguraran que los materiales biológicos fabricados con productos de sangre humana no estuvieran contaminados por el VIH-1. Fuente: TRIKOOBA.COM La ‘vacuna COVID’ no es una vacuna, afirman los doctores David Martin y Judy Mikovits 30 enero 2021 "es un sistema operativo" NO es una vacuna. La vacuna COVID de ARNm que se está desplegando en muchos países del mundo, NO es una vacuna. Repito: no es una vacuna. Es muchas cosas, pero una vacuna no es una de ellas. Tenemos que despertar al hecho de que la farsa de la pandemia de COVID ha acelerado rápidamente los aspectos tecnocráticos y transhumanistas del Nuevo Orden Mundial (NWO) hasta el punto de que la gente está haciendo cola ciegamente para ser inyectada con un “tratamiento” que es también un dispositivo químico, un sistema operativo, un patógeno sintético y un dispositivo de producción de patógenos químicos. ***************************** ATTENTION: Dr. David Martin won a lawsuit against the order of "masks" on planes But he won't stop there "It's about the criminals of the poison" Here is his resume: Dr. David Martin Resume His titles: 1. Dr. David E. Martin is the founder and president of M-CAM Inc, an international leader in financing innovation, trade and financing of intangible assets. He is the creator of the first innovation-based quantitative public equity index and is the managing partner of the Purple Bridge Funds. He is the creator of the world's first quantitative public equity index: the CNBC IQ100 powered by M-CAM. Actively engaged in global ethical economic development, Dr. Martin's work includes financial engineering and investment, speaking, writing, and providing financial advisory services to most countries around the world. Dr. Martin is the architect and founder of the Global Innovation Commons and is the author of the international legal framework for the Heritable Knowledge Trust and Heritable Innovation Trust programs. He has pioneered global programs to bring corporate and stock market transparency to multinational extractive industries and has been instrumental in repatriating value to countries that have been subject to corporate and financial abuse. His work on ethical engagement and stewardship of community-based value interests and the commons is at the forefront of global financial innovation. Dr. Martin is a Batten Scholar at the University of Virginia's Darden Graduate School of Business Administration. He has been Chair of Economic Innovation at the UN-affiliated Intergovernmental Renewable Energy Organization and has been an advisor to numerous central banks, world economic forums, the World Bank and the International Finance Corporation, as well as national governments. 2. Dr. Judy Mikovits received her bachelor's degree in chemistry with a minor in biology from the University of Virginia in 1980 and her Ph.D. in biochemistry and molecular biology from George Washington University in 1992. Upon graduating from the University of Virginia, she joined National Cancer Institute in Frederick Maryland, where he developed purification methods for interferon alpha. It was this interferon that was used in the first immunotherapy treatment for hairy cell leukemia in 1986. In 1986-7, before enrolling in graduate school, he went to Upjohn Pharmaceuticals in Kalamazoo Michigan to develop production methods that would ensure that biological materials made from human blood products were not contaminated by HIV-1. Source: TRIKOOBA.COM The 'COVID vaccine' is not a vaccine, say doctors David Martin and Judy Mikovits 30 January 2021 "it's an operating system" It is NOT a vaccine. The mRNA COVID vaccine being rolled out in many countries around the world is NOT a vaccine. I repeat: it is not a vaccine. It is many things, but a vaccine is not one of them. We need to wake up to the fact that the farce of the COVID pandemic has rapidly accelerated the technocratic and transhumanist aspects of the New World Order (NWO) to the point where people are blindly lining up to be injected with a “treatment” that is also a chemical device, an operating system, a synthetic pathogen, and a chemical pathogen production device

View Less

Like October 24, 2022